{"id":120,"date":"2024-11-21T10:59:40","date_gmt":"2024-11-21T09:59:40","guid":{"rendered":"https:\/\/clls-symposium.org\/?page_id=120"},"modified":"2025-04-15T16:01:32","modified_gmt":"2025-04-15T14:01:32","slug":"programme","status":"publish","type":"page","link":"https:\/\/clls-symposium.org\/?page_id=120","title":{"rendered":"Programme"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The final programme is available <a href=\"https:\/\/cm.siopeurope.eu\/cmPortal\/searchable\/CLLS2025\/config\/normal#!sessionschedule\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a>.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size\" style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.625), 20px);\"><a class=\"wp-block-button__link has-contrast-3-background-color has-background wp-element-button\" href=\"https:\/\/cm.siopeurope.eu\/cmPortal\/searchable\/CLLS2025\/config\/normal#!sessionschedule\" target=\"_blank\" rel=\"noreferrer noopener\">Final Progamme<\/a><\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">Programme at a Glance<\/h2>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table class=\"has-contrast-color has-text-color has-link-color\"><thead><tr><th><\/th><th class=\"has-text-align-left\" data-align=\"left\">Saturday 10 May 2025<\/th><\/tr><\/thead><tbody><tr><td>13.00-13.45<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>Opening Lecture by the Hungarian Host<br><\/strong>Past, present and future of the ALL-IC BFM trials<br><em>Cszongor Kiss (HU), Gabor Kovacs (HU)<\/em><\/td><\/tr><tr><td>14.00-16.10<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>Myeloid Disorders<br><\/strong>How molecular-genetics shaped the diagnosis and current treatment of JMML<br><em>Charlotte Niemeyer (DE)<br><\/em><br>Oral Abstracts (4)<\/td><\/tr><tr><td>16.10-16.30<\/td><td class=\"has-text-align-left\" data-align=\"left\">Coffee break<\/td><\/tr><tr><td>16.30-18.40<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>Acute Lymphoblastic Leukemia<br><\/strong>Is intensive chemotherapy needed for cure of primary acute lymphoblastic leukemia?<br><em>Andrea Biondi (IT)<\/em><br><br>Oral Abstracts (4)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th><\/th><th class=\"has-text-align-left\" data-align=\"left\">Sunday 11 May 2025<\/th><\/tr><\/thead><tbody><tr><td>8.30-10.40<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong><strong>Acute Lymphoblastic Leukemia<\/strong><\/strong><br>Shall we sequence all patients with leukemia for known cancer predisposition genes?<br><em>Jette Bakhuizen (NL)<\/em><br><br>Oral Abstracts (4)<\/td><\/tr><tr><td>10.40-11.00<\/td><td class=\"has-text-align-left\" data-align=\"left\">Coffee break<\/td><\/tr><tr><td>11.00-12.40<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>ALL Continued\/Non-Hodgkin&#8217;s Lymphoma<\/strong><br>How molecular-genetics complement stage of disease in stratification of pediatric NHL<br><em>Birgit Burkhardt (DE)<\/em><br><em><br><\/em><br>Oral Abstracts (3)<\/td><\/tr><tr><td>12.40-13.30<\/td><td class=\"has-text-align-left\" data-align=\"left\">Lunch<\/td><\/tr><tr><td>13.30-16.00<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>Poster Session<\/strong><\/td><\/tr><tr><td>16.00-16.30<\/td><td class=\"has-text-align-left\" data-align=\"left\">Coffee break<\/td><\/tr><tr><td>16.30-18.10<\/td><td class=\"has-text-align-left\" data-align=\"left\"><strong>Cellular Therapies<br><\/strong>CART-cell therapy lessons learned from the GoCART Real World Data of the EBMT<br><em>Adriana Balduzzi (IT)<\/em><br><br>Oral abstracts (3)<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>The final programme is available here. Programme at a Glance Saturday 10 May 2025 13.00-13.45 Opening Lecture by the Hungarian HostPast, present and future of the ALL-IC BFM trialsCszongor Kiss (HU), Gabor Kovacs (HU) 14.00-16.10 Myeloid DisordersHow molecular-genetics shaped the diagnosis and current treatment of JMMLCharlotte Niemeyer (DE)Oral Abstracts (4) 16.10-16.30 Coffee break 16.30-18.40 Acute [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-120","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/pages\/120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clls-symposium.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=120"}],"version-history":[{"count":6,"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/pages\/120\/revisions"}],"predecessor-version":[{"id":177,"href":"https:\/\/clls-symposium.org\/index.php?rest_route=\/wp\/v2\/pages\/120\/revisions\/177"}],"wp:attachment":[{"href":"https:\/\/clls-symposium.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}